[1] 王晓凯,张志成,孙天胜.SIRT1的生理作用及调控机制的研究进展[J].中华临床医师杂志,2011,5(24):7315-7318.
[2] PICARD F,KURTEV M,CHUNG N,et al.Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-γ[J].Nature,2004,429(6993):771-776.
[3] MANNEN H.Identification and utilization of genes associated with beef qualities[J].Animal Science Journal,2011,82(1):1-7.
[4] TANIGUCHI M,GUAN L L,ZHANG B,et al.Gene expression patterns of bovine perimuscular pre-adipocytes during adipogenesis[J].Biochemical and Biophysical Research Communications,2008,366(2):346-351.
[5] FERNYHOUGH M E,HELTERLINE D I,VIERCK J L,et al.Dedifferentiation of mature adipocytes to form adipofibroblasts:more than just a possibility[J].Adipocytes,2005,1(1):17-24.
[6] WANG Y H,BYRNE K A,REVERTER A,et al.Transcriptional profiling of skeletal muscle tissue from two breeds of cattle[J].Mammalian Genome,2005,16(3):201-210.
[7] LEHNERT S A,REVERTER A,BYRNE K A,et al.Gene expression studies of developing bovine
longissimus muscle from two different beef cattle breeds[J].BMC Developmental Biology,2007,7(1):95.
[8] ZHANG Q K,LEE H G,HAN J A,et al.Differentially expressed proteins during fat accumulation in bovine skeletal muscle[J].Meat Science,2010,86(3):814-820.
[9] LEE S H,GONDRO C,VAN DER WERF J,et al.Use of a bovine genome array to identify new biological pathways for beef marbling in Hanwoo (Korean Cattle)[J].BMC Genomics,2010,11(1):623.
[10] ANGHEL S I,WAHLI W.Fat poetry:a kingdom for PPARγ[J].Cell Research,2007,17(6):486-511.
[11] CHRISTODOULIDES C,VIDAL-PUIG A.PPARs and adipocyte function[J].Molecular and Cellular Endocrinology,2010,318(1/2):61-68.
[12] WHITE U A,STEPHENS J M.Transcriptional factors that promote formation of white adipose tissue[J].Molecular and Cellular Endocrinology,2010,318(1/2):10-14.
[13] SIERSBÆK R,NIELSEN R,MANDRUP S.PPARγ in adipocyte differentiation and metabolism-novel insights from genome-wide studies[J].FEBS Letters,2010,584(15):3242-3249.
[14] TONTONOZ P,SPIEGELMAN B M.Fat and beyond:the diverse biology of PPARγ[J].Annual Review of Biochemistry,2008,77(1):289-312.
[15] SHARMA A M,STAELS B.Review:peroxisome proliferator-activated receptor γ and adipose tissue-understanding obesity-related changes in regulation of lipid and glucose metabolism[J].Journal of Clinical Endocrinology and Metabolism,2007,92(2):386-395.
[16] FARMER S R.Regulation of PPARγ activity during adipogenesis[J].International Journal of Obesity,2005,29:S13-S16.
[17] KERSTEN S,DESVERGNE B,WAHLI W.Roles of PPARs in health and disease[J].Nature,2000,405(6785):421-424.
[18] SHIMANO H.Sterol regulatory element-binding proteins (SREBPs):transcriptional regulators of lipid synthetic genes[J].Progress in Lipid Research,2001,40(6):439-452.
[19] EBERLÉ D,HEGARTY B,BOSSARD P,et al.SREBP transcription factors:master regulators of lipid homeostasis[J].Biochimie,2004,86(11):839-848.
[20] BERNARD L,LEROUX C,CHILLIARD Y.Expression and nutritional regulation of lipogenic genes in the ruminant lactating mammary gland[J].Advances in Experimental Medicine and Biology,2008,606:67-108.
[21] KIM J B,SPIEGELMAN B M.ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism[J].Genes & Development,1996,10(9):1096-1107.
[22] KIM J B,WRIGHT H M,WRIGHT M,et al.ADD1/SREBP1 activates PPARγ through the production of endogenous ligand[J].Proceedings of the National Academy of Sciences of the United States of America,1998,95(8):4333-4337.
[23] GRAUGNARD D E,BERGER L L,FAULKNER D B,et al.High-starch diets induce precocious adipogenic gene network up-regulation in longissimus lumborum of early-weaned Angus cattle[J].British Journal of Nutrition,2010,103(7):953-963.
[24] LEFTEROVA M I,LAZAR M A.New developments in adipogenesis[J].Trends in Endocrinology & Metabolism,2009,20(3):107-114.
[25] PICARD F,GUARENIE L.Molecular links between aging and adipose tissue[J].International Journal of Obesity,2005,29(Suppl.1):S36-S39.
[26] FREYTAG S O,PAIELLI D L,GILBERT J D.Ectopic expression of the CCAAT/enhancer-binding protein α promotes the adipogenic program in a variety of mouse fibroblastic cells[J].Genes & Development,1994,8(14):1654-1663.
[27] MOYNIHAN K A,IMAI S I.Sirt1 as a key regulator orchestrating the response to caloric restriction[J].Drug Discovery Today,2006,3(l):11-17.
[28] QIANG L,WANG L H,KON N,et al.Brown remodeling of white adipose tissue by Sirt1-dependent deacetylation of PPARγ[J].Cell,2012,150(3):620-632.
[29] CHALKIADAKI A,GUARENTE L.High-fat diet triggers inflammation-induced cleavage of SIRT1 in adipose tissue to promote metabolic dysfunction[J].Cell Metabolism,2012,16(2):180-188.
[30] COSTA C D S,HAMMES T O,ROHDEN F,et al.SIRT1 transcription is decreased in visceral adipose tissue of morbidly obese patients with severe hepatic steatosis[J].Obesity Surgery,2010,20(5):633-639.
[31] GILLUM M P,KOTAS M E,ERION D M,et al.SIRT1 regulates adipose tissue inflammation[J].Diabetes,2010,60(12):3235-3245.
[32] SEALE P,KAJIMURA S,YANG W L,et al.Transcriptional control of brown fat determination by PRDM16[J].Cell Metabolism,2007,6(1):38-54.
[33] XU C,BAI B,FAN P C,et al.Selective overexpression of human SIRT1 in adipose tissue enhances energy homeostasis and prevents the deterioration of insulin sensitivity with ageing in mice[J].American Journal of Translation Research,2013,5(4):412-426.
[34] ST-PIERRE J,LIN J D,KRAUSS S,et al.Bioenergetic analysis of peroxisome proliferator-activated receptor γ coactivators 1α and 1β (PGC-1α and PGC-1β) in muscle cells[J].Journal of Biological Chemistry,2003,278(29):26597-26603.
[35] LOUET J F,HAYHURST G,GONZALEZ F J,et al.The coactivator PGC-1 is involved in the regulation of the liver carnitine palmitoyltransferase I gene expression by cAMP in combination with HNF4α and cAMP-response element-binding protein (CREB)[J].Journal of Biological Chemistry,2002,277(41):37991-38000.
[36] BOUTANT M,JOFFRAUD M,KULKARNI S S,et al.SIRT1 enhances glucose tolerance by potentiating brown adipose tissue function[J].Molecular Metabolism,2015,4(2):118-131.
[37] BORDONE L,COHEN D,ROBINSON A,et al.SIRT1 transgenic mice show phenotypes resembling calorie restriction[J].Aging Cell,2007,6(6):759-767.
[38] LI X L,ZANG S W,BLANDER G,et al.SIRT1 deacetylates and positively regulates the nuclear receptor LXR[J].Molecular Cell,2007,28(1):91-106.
[39] PONUGOTI B,KIM D H,XIAO Z,et al.SIRT1 deacetylates and inhibits SREBP-1C activity in regulation of hepatic lipid metabolism[J].Journal of Biological Chemistry,2010,285(44):33959-33970.
[40] RODGERS J T,PUIGSERVER P.Fasting-dependent glucose and lipid metabolic response through hepatic sirtuin1[J].Proceedings of the National Academy of Sciences of the United States of America,2007,104(31):12861-12866.
[41] WALKER A K,YANG F J,JIANG K R,et al.Conserved role of SIRT1 or thologs in fasting-dependent in hibition of the lipid/cholesterol regulator or SREBP[J].Genes & Development,2010,24(13):1403-1417.
[42] KEMPER J K,XIAO Z,PONUGOTI B,et al.FXR acetylation is normally dynamically regulated by p300 and SIRT1 but constitutively elevated in metabolic disease states[J].Cell Metabolism,2009,10(5):392-404.
[43] PURUSHOTHAM A,XU Q,LU J,et al.Hepatic deletion of SIRT1 decreases hepatocyte nuclear factor 1α/farnesoid X receptor signaling and induces formation of cholesterol gallstones in mice[J].Molecular and Cellular Biology,2012,32(7):1226-1236.
[44] KALAANY N Y,MANGELSDORF D J.LXRS and FXR:the yin and yang of cholesterol and fat metabolism[J].Annual Review of Physiology,2006,68(1):159-191.
[45] GUARENTE L.Sirtuins,aging,and medicine[J].The New England Journal of Medicine,2011,364(23):2235-2244.
[46] KITADA M,KUME S,TAKEDA-WATANABE A,et al.Sirtuins and renal diseases:relationship with aging and diabetic nephropathy[J].Clinical Science,2013,124(3):153-164.
[47] HOU X Y,XU S Q,MAITLAND-TOOLAN K A,et al.SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase[J].Journal of Biological Chemistry,2008,283(29):20015-20026.
[48] STEINBERG G R,KEMP B E.AMPK in health and disease[J].Physiological Reviews,2009,89(3):1025-1078.
[49] CANTÓ C,GERHART-HINES Z,FEIGE Z N,et al.AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity[J].Nature,2009,458(7241):1056-1060.
[50] CARLING D,ZAMMIT V A,HARDIE D G.A common bicyclic protein kinase cascade inactivates the regulatory enzymes of fatty acid and cholesterol biosynthesis[J].FEBS Letters,1987,223(2):217-222.
[51] HARDIE D G,CARLING D,CARLSON M.The AMP-activated/SNF1 protein kinase subfamily:metabolic sensors of the eukaryotic cell[J].Annual Review of Biochemistry,1998,67(1):821-855.
[52] LASS A,ZIMMERMANN R,OBERER M,et al.Lipolysis-a highly regulated multi-enzyme complex mediates the catabolism of cellular fat stores[J].Progress in Lipid Research,2011,50(1):14-27.
[53] CHAKRABARTI P,KANDROR K V.FoxO1 controls insulindependent adipose triglyceride lipase (ATGL) expression and lipolysis in adipocytes[J].Journal of Biological Chemistry,2009,284 (20):13296-13300.
[54] CHENG Z Y,WHITE M F.Targeting Forkhead box O1 from the concept to metabolic diseases:lessons from mouse models[J].Antioxidants & Redox Signaling,2011,14(4):649-661.
[55] LOMB D J,LAURENT G,HAIGIS M C.Sirtuins regulate key aspects of lipid metabolism[J].Biochimica et Biophysica Acta:Proteins and Proteomics,2010,1804(8):1652-1657.
[56] CHAKRABARTI P,ENGLISH T,KARKI S,et al.SIRT1 controls lipolysis in adipocytes via FoxO1-mediated expression of ATGL[J].Journal of Lipid Research,2011,52(9):1693-1701.
[57] CHEN W L,KANG C H,WANG S G,et al.α-lipoic acid regulates lipid metabolism through induction of sirtuin 1 (SIRT1) and activation of AMP-activated protein kinase[J].Diabetologia,2012,55(6):1824-1835.
[58] HUANG C H,SHIN S M,WU M T,et al.Monacolin K affects lipid metabolism through SIRT1/AMPK pathway in HepG2 cells[J].Archives of Pharmacal Research,2013,36(12):1541-1551.
[59] HENIN N,VINCENT M F,GRUBER H E,et al.Inhibition of fatty acid and cholesterol synthesis by stimulation of AMP-activated protein kinase[J].FASEB Journal,1995,9(7):541-546.
[60] ENDO A,HASUMI K.Biochemical aspect of HMG CoA reductase inhibitors[J].Advances in Enzyme Regulation,1989,28:53-64.
[61] MANNING B D,CANTLEY L C.AKT/PKB signaling:navigating downstream[J].Cell,2007,129(7):1261-1274.
[62] HORTON J D,GOLDSTEIN J L,BROWN M S.SREBPs:activators of the complete program of cholesterol and fatty acid synthesis in the liver[J].Journal of Clinical Investigation,2002,109(9):1125-1131.
[63] PORSTMANN T,GRIFFITHS B,CHUNG Y L,et al.PKB/Akt induces transcription of enzymes involved in cholesterol and fatty acid biosynthesis via activation of SREBP[J].Oncogene,2005,24(43):6465-6481.
[64] DVVEL K,YECIES J L,MENON S,et al.Activation of a metabolic gene regulatory network downstream of mTOR complex 1[J].Molecular Cell,2010,39(2):171-183.
[65] PORSTMANN T,SANTOS C R,GRIFFITHS B,et al.SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth[J].Cell Metabolism,2008,8(3):224-236.
[66] YEH W C,BIERER B E,MCKNIGHT S L.Rapamycin inhibits clonal expansion and adipogenic differentiation of 3T3-L1 cells[J].Proceedings of the National Academy of Sciences of the United States of America,1995,92(24):11086-11090.
[67] ROSEN E D,HSU C H,WANG X,et al.C/EBPα induces adipogenesis through PPARγ:a unified pathway[J].Genes & Development,2002,16(1):22-26.
[68] ZHANG H H,HUANG J X,DVVEL K,et al.Insulin stimulates adipogenesis through the Akt-TSC2-mTORC1 pathway[J].PLoS One,2009,4(7):e6189.
[69] POLAK P,CYBULSKI N,FEIGE J N,et al.Adipose-specific knockout of raptor results in lean mice with enhanced mitochondrial respiration[J].Cell Metabolism,2008,8(5):399-410.
[70] KIM J E,CHEN J.Regulation of peroxisome proliferator-activated receptor-γ activity by mammalian target of rapamycin and amino acids in adipogenesis[J].Diabetes,2004,53(11):2748-2756.
[71] YU W H,CHEN Z G,ZHANG J L,et al.Critical role of phosphoinositide 3-kinase cascade in adipogenesis of human mesenchymal stem cells[J].Molecular and Cellular Biochemstry,2008,310(1/2):11-18.
[72] EL-CHAÂR D,GAGNON A,SORISKY A.Inhibition of insulin signaling and adipogenesis by rapamycin:effect on phosphorylation of p70 S6 kinase vs eIF4E-BP1[J].International Journal of Obesity,2004,28(2):191-198
[73] LE BACQUER O,PETROULAKIS E,PAGLIALUNGA S,et al.Elevated sensitivity to diet-induced obesity and insulin resistance in mice lacking 4E-BP1 and 4E-BP2[J].Journal of Clinical Investigation,2007,117(2):387-396.
[74] LAPLANTE M,HORVAT S,FESTUCCIA W T,et al.DEPTOR cell-autonomously promotes adipogenesis,and its expression is associated with obesity[J].Cell Metabolism,2012,16(2):202-212.
[75] CHAKRABARTI P,ENGLISH T,SHI J,et al.Mammalian target of rapamycin complex 1 suppresses lipolysis stimulates lipogenesis and promotes fat storage[J].Diabetes,2010,59(4):775-781.
[76] SOLIMAN G A,ACOSTA-JAQUEZ H A,FINGAR D C.mTORC1 inhibition via rapamycin promotes triacylglycerol lipolysis and release of free fatty acids in 3T3-L1 adipocytes[J].Lipids,2010,45(12):1089-1100.
[77] KUMAR A,LAWRENCE J C,Jr.,JUNG D Y,et al.Fat cell-specific ablation of
rictor in mice impairs insulin-regulated fat cell and whole-body glucose and lipid metabolism[J].Diabetes,2010,59(6):1397-1406.
[78] WANG H,ECKEL R H.Lipoprotein lipase:from gene to obesity[J].American Journal of Physiology:Endocrinology and Metabolism,2009,297(2):E271-E288.
[79] UM S H,FRIGERIO F,WATANABE M,et al.Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity[J].Nature,2004,431(7005):200-205.
[80] HAY N,SONENBERG N.Upstream and downstream of mTOR[J].Genes & Development,2004,18(16):1926-1945.
[81] WULLSCHLEGER S,LOEWITH R,HALL M N.TOR signaling in growth and metabolism[J].Cell,2006,124(3):471-484.
[82] GHOSH H S,MCBURNEY M,ROBBINS P D.SIRT1 negatively regulates the mammalian target of rapamycin[J].PLoS One,2010,5(2):e9199.
[83] 赵涛涛,赵霞,景旭斌,等.雷帕霉素靶蛋白(mTOR)信号通路参与沉默信息调节因子1(Sirt1)抑制小鼠脂肪沉积[J].农业生物技术学报,2012,20(4):404-410.
